This study demonstrated for the first time the potential of VEGFR1 and FSHR, by ultrasound-based molecular imaging, to follow-up the longitudinal response to sunitinib in ccRCC. This evidence concerns the gene FSHR and nonpapillary renal cell carcinoma.